Texans appear to be OK with embracing AI. Image via Getty Images

When new technology emerges, many of us approach it with a certain amount of skepticism. That’s certainly true with artificial intelligence, which is creeping into practically every part of our existence. Pew Research Center surveys show that more than half (52 percent) of Americans are increasingly cautious about the growing presence of AI in their everyday lives.

So, how wary are Texans of AI? A new ranking from ZapCap, whose AI generates captions for videos, gives us a clue. Texas ranks 15th among the states that are most trusting of AI, with a trust score of 85 out of 100.

Translation: Texans appear to be OK with embracing AI.

To develop the ranking, ZapCap collected search volume data for AI-related queries, including terms such as “best AI tools,” “best AI assistants,” “how to use AI” and “ChatGPT.” ZapCap then calculated a trust score based on each state’s search activity and population.

“This research provides an insightful look into AI engagement patterns across the U.S., highlighting the states where AI is most actively explored and potentially trusted,” says ZapCap.

With an off-the-charts score of 116, California tops the list. California “demonstrates extraordinary AI engagement with over 44 million ChatGPT searches and 77,910 Claude.AI queries, marking the highest AI tool adoption rates across all metrics,” says ZapCap.

Here’s the rest of the top five, including their AI trust scores:

  • New York — 108
  • Massachusetts — 106
  • Virginia — 102
  • New Jersey — 99

The state with the least amount of AI trust is Minnesota, which received a ZapCap score of 22.

“What’s fascinating is that innovation is blooming far beyond the usual tech hotspots,” ZapCap’s Jessica Bui said in a release. “While California and New York continue to lead, states like Massachusetts and Virginia are rising as innovation powerhouses. Their rapid adoption of new technology proves that it's not about market size — it’s about fostering a culture where businesses and everyday people feel confident exploring what's next.”

See the full findings here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.